Private Market View

Hankang Capital

Venture capital · Shanghai, China

AUM
$280.9M
Portfolio companies
22
Recorded deals
81
13 in last 12M
Last investment

Key facts

  • Hankang Capital is a venture capital firm based in Shanghai, China with 22 tracked portfolio companies.
  • Notable positions include CuroVax, Zenshine Pharmaceuticals (Nanjing) Group, Highlightll Pharma, Sirius Therapeutics, Huadao Biopharma.

About Hankang Capital

Founded in 2010, Hankang Capital is a corporate venture capital firm of Zhongjianxin Group headquartered in Shanghai, China. The firm focuses on making investments in sectors like biomedicine, medical equipment, diagnostic reagents, medical services and other major health fields.

Free account
See the whole book
  • ·The book's top 25 — of 22 recorded positions
  • ·Watchlist + alerts for Hankang Capital's activity
Create free account
No card required

Portfolio, priced

22 companies · by our current valuations
CompanyValuationRole
CuroVax$405.0M
Zenshine Pharmaceuticals (Nanjing) Group$354.4M
Highlightll Pharma$346.2M
Sirius Therapeutics$252.5M
Huadao Biopharma$79.9M
LeadingTac$8.5M
Microwave Bio
AusperBio
Phrontline Biopharma
Pinnacle Medicines
Proviva Therapeutics
Puhe Pharmaceutical
SciBrunch Therapeutics
Sumgen
VelaVigo
+ 7 more companies · a free account shows the top of the book

Frequently asked

What companies does Hankang Capital invest in?
Hankang Capital has 22 recorded portfolio companies, including CuroVax, Zenshine Pharmaceuticals (Nanjing) Group, Highlightll Pharma, Sirius Therapeutics.
What is Hankang Capital's AUM?
Hankang Capital manages approximately $280.9M in assets.